Last Updated: June 18, 2019
Result type: Reports
Generic Name: semaglutide
Indications: Diabetes mellitus, type 2
Last Updated: May 13, 2021
Result type: Reports
Generic Name: patiromer
Indications: For the treatment of hyperkalemia in adults with chronic
kidney disease (eGFR ≥15mL/min/1.73m).
Last Updated: May 13, 2021
Result type: Reports
Generic Name: semaglutide
Indications: As an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus: as monotherapy when metformin is considered inappropriate due to intolerance or contraindications; in combination with other medicinal products for the treatment of diabetes
Last Updated: May 13, 2021
Result type: Reports
Generic Name: dupilumab
Indications: Dupixent is indicated as an add-on maintenance treatment in patients aged 12 years and older with severe asthma with a type 2/eosinophilic phenotype or oral corticosteroid-dependent asthma.
Last Updated: May 13, 2021
Result type: Reports
Generic Name: risdiplam
Indications: For the treatment of spinal muscular atrophy (SMA) in patients 2 months and older.
Last Updated: May 13, 2021
Result type: Reports
Research Type: Drug
Last Updated: May 13, 2021
Result type: Reports
Research Type: Non - Surgical Procedure
Last Updated: May 13, 2021
Result type: Reports
Research Type: Medical Device
Last Updated: May 12, 2021
Result type: Reports
Generic Name: tralokinumab
Indications: Tralokinumab is indicated for the treatment of moderate-to-severe atopic dermatitis (AD) in adult patients whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. TRADENAME (tralokinumab) can be used with or without topical corticosteroids.
Last Updated: May 12, 2021
Result type: Reports
Generic Name: von Willebrand Factor [recombinant]
Indications: Indicated for: Treatment and Control of bleeding episodes in adults (age ≥18) diagnosed with von Willebrand Disease (VWD).Perioperative management of bleeding in adults (age ≥18) diagnosed with VWD
